Clinical Trials Logo

Clinical Trial Summary

The aim of the study was to evaluate the efficacy of orally administered bovine lactoferrin (bLF) on Urinary Tract Infections in neonates and infants. Fifty-five patients with urinary tract infection were randomized to receive either bLF (n = 27) or an identical placebo (n = 28) for 4 weeks. The patients were assessed clinically and laboratory.


Clinical Trial Description

This study was a prospective randomized controlled trial at a single university medical center. Participants were neonates or infants with Urinary Tract Infection (UTI) admitted to the Neonatal and Infant Pathology Department of Children's University Hospital in the period from July 2015 to December 2017. The intervention was bovine lactoferrin at a dosage of 100 mg/day for a period of 4 weeks compared with placebo in a control group. During hospital treatment, laboratory tests were performed to evaluate the activity of inflammatory markers (C-reactive protein, procalcitonin, Interleukin-6 and Interleukin-8 levels and white blood cell count). Fifty-five patients heve been included in the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06109688
Study type Interventional
Source Medical University of Lublin
Contact
Status Completed
Phase Phase 3
Start date July 1, 2015
Completion date February 15, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05066854 - INterest of the Negative Predictive Value of Integrons in Choosing a Narrow-spectrum Empirical anTibiotic Treatment vs Usual Empirical Antibiotic Treatment for Urinary Tract infectionS in the PEDiatric Emergency Department N/A
Recruiting NCT04278404 - Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Recruiting NCT04654507 - Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children Phase 3
Completed NCT03263845 - Evaluation of Pain in Urinary Collections in Pediatric Emergencies in Children Who Have Not Acquired Cleanliness N/A
Recruiting NCT04608851 - Preventing Urinary Tract Infections With E. Coli Nissle: Phase 4
Recruiting NCT03825874 - Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Children
Withdrawn NCT06273098 - School-Based Bladder Health Intervention N/A
Recruiting NCT03221504 - 7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children N/A
Recruiting NCT05819229 - Oral Antibiotics Alone in Children Aged 4 Weeks to 2 Months With a Urinary Tract Infection
Terminated NCT04763967 - A Study of the PedSCath Pediatric Sampling Catheter Versus Current Standard of Care.
Completed NCT04066621 - PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT) Phase 4